Nat. Med. 29, 1370–1378 (2023). Article CAS PubMed PubMed Central Google Scholar Liu, T. C. et al. An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency. Mol. Ther. 9, 786–803 (2004). Article CAS ...
As Li-ion batteries are increasingly being deployed in electric vehicles and grid-level energy storage, the demand for Li is growing rapidly. Extracting lithium from alternative aqueous sources such as geothermal brines plays an important role in meeting this demand. Electrochemical intercalation emerges...
We first synthesized the copper precursor using a facile hydrolysis method (see the “Methods” section), which yielded carbon-supported Cu2Cl(OH)3nanoparticles (Supplementary Figs.1–5). To form the Cu NDs catalyst, we sprayed the precursor onto the GDL, which was subjected to the in situ ...
The trial protocol was approved by the Institutional Reviewer Board of Fudan University Shanghai Cancer Center and BGI (NO. 1703170–15 and NO. BGI-IRB 19151-T2), and the trial was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. Informed consent wa...
Boehm, K. M. et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.Nat. Cancer3, 723–733 (2022). CASPubMedPubMed CentralGoogle Scholar Ulz, P. et al. Inferring expressed genes by whole-genome sequencing of plasma DNA.Nat...
Nat. Commun. 8, 14432 (2017). Article ADS CAS PubMed PubMed Central Google Scholar Negi, S. S. & Brown, P. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis. Oncotarget 6, 18094–18104 (2015)...
Peer reviewer reports are available. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary information Supplementary Information Peer Review File Description of Additional Supplementary Files Supplementary Data 1 ...
The primary endpoint is the proportion of patients alive and progression-free at 6 months (PFS-6). Secondary endpoints include progression-free and overall survival, best intracranial response, and toxicity. Our study has met its primary endpoint and achieved a PFS-6 rate of 0.48 (90% exact ...
Murphy, M. Taylor and the other anonymous reviewer(s) for their contribution to the peer review of this work. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Extended data figures and tables Extended Data Figure...
Nat. Commun. 8, 14432 (2017). Article ADS CAS PubMed PubMed Central Google Scholar Negi, S. S. & Brown, P. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis. Oncotarget 6, 18094–18104 (2015)...